Surgical aortic valve replacement in Australia, 2002–2015

temporal changes in clinical practice, patient profiles and outcomes

Si Si, Graham S. Hillis, Frank M. Sanfilippo, Julian Smith, Lavinia Tran, Christopher M. Reid, Tom Briffa

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: This study describes the temporal changes in risk profiles and outcomes among patients with aortic stenosis (AS) undergoing surgical aortic valve replacement (SAVR) in Australia between 2002 and 2015. Methods: Using the Australian and New Zealand Society of Cardiac and Thoracic Surgeons database, we identified first-recorded SAVR for AS over 14 years. Patients’ surgical risk profiles, procedures, 30-day and 12-month outcomes were summarized before and after the introduction of transcatheter aortic valve implantation in Australia, in 2008. We applied multivariable regression models to investigate the changes over time on risk-adjusted 30-day mortality, re-hospitalization and 12-month mortality. Results: We identify a total of 18 147 patients with AS who underwent SAVR; mostly men (64%) with a mean age of 72 years. The proportion of major cardiac surgeries devoted to SAVR increased from 14% in 2002 to 20% in 2015. More SAVRs were performed electively (80% in 2002 versus 86% in 2015), and the recipients were at lower surgical risk (mean multi-risk score 3.9% in 2002 versus 3.0% in 2015). The use of bioprosthetic aortic valves increased over time (67% in 2002 to 88% in 2015). We found no significant changes in 30-day mortality, a significant decrease in 30-day readmission and minor fluctuations in 12-month mortality over the study period. Conclusion: SAVR comprises an increasingly larger proportion of all adult cardiac surgeries in Australia. There has been a greater use of bioprosthetic aortic valves, a fall in 30-day readmission but no significant changes in mortality.

Original languageEnglish
Pages (from-to)1061-1067
Number of pages7
JournalANZ Journal of Surgery
Volume89
Issue number9
DOIs
Publication statusPublished - Sep 2019

Keywords

  • aortic stenosis
  • surgical aortic valve replacement
  • time trend

Cite this

@article{efe32eb647ed4baea1292d8322b4de2f,
title = "Surgical aortic valve replacement in Australia, 2002–2015: temporal changes in clinical practice, patient profiles and outcomes",
abstract = "Background: This study describes the temporal changes in risk profiles and outcomes among patients with aortic stenosis (AS) undergoing surgical aortic valve replacement (SAVR) in Australia between 2002 and 2015. Methods: Using the Australian and New Zealand Society of Cardiac and Thoracic Surgeons database, we identified first-recorded SAVR for AS over 14 years. Patients’ surgical risk profiles, procedures, 30-day and 12-month outcomes were summarized before and after the introduction of transcatheter aortic valve implantation in Australia, in 2008. We applied multivariable regression models to investigate the changes over time on risk-adjusted 30-day mortality, re-hospitalization and 12-month mortality. Results: We identify a total of 18 147 patients with AS who underwent SAVR; mostly men (64{\%}) with a mean age of 72 years. The proportion of major cardiac surgeries devoted to SAVR increased from 14{\%} in 2002 to 20{\%} in 2015. More SAVRs were performed electively (80{\%} in 2002 versus 86{\%} in 2015), and the recipients were at lower surgical risk (mean multi-risk score 3.9{\%} in 2002 versus 3.0{\%} in 2015). The use of bioprosthetic aortic valves increased over time (67{\%} in 2002 to 88{\%} in 2015). We found no significant changes in 30-day mortality, a significant decrease in 30-day readmission and minor fluctuations in 12-month mortality over the study period. Conclusion: SAVR comprises an increasingly larger proportion of all adult cardiac surgeries in Australia. There has been a greater use of bioprosthetic aortic valves, a fall in 30-day readmission but no significant changes in mortality.",
keywords = "aortic stenosis, surgical aortic valve replacement, time trend",
author = "Si Si and Hillis, {Graham S.} and Sanfilippo, {Frank M.} and Julian Smith and Lavinia Tran and Reid, {Christopher M.} and Tom Briffa",
year = "2019",
month = "9",
doi = "10.1111/ans.15370",
language = "English",
volume = "89",
pages = "1061--1067",
journal = "ANZ Journal of Surgery",
issn = "1445-1433",
publisher = "Wiley-Blackwell",
number = "9",

}

Surgical aortic valve replacement in Australia, 2002–2015 : temporal changes in clinical practice, patient profiles and outcomes. / Si, Si; Hillis, Graham S.; Sanfilippo, Frank M.; Smith, Julian; Tran, Lavinia; Reid, Christopher M.; Briffa, Tom.

In: ANZ Journal of Surgery, Vol. 89, No. 9, 09.2019, p. 1061-1067.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Surgical aortic valve replacement in Australia, 2002–2015

T2 - temporal changes in clinical practice, patient profiles and outcomes

AU - Si, Si

AU - Hillis, Graham S.

AU - Sanfilippo, Frank M.

AU - Smith, Julian

AU - Tran, Lavinia

AU - Reid, Christopher M.

AU - Briffa, Tom

PY - 2019/9

Y1 - 2019/9

N2 - Background: This study describes the temporal changes in risk profiles and outcomes among patients with aortic stenosis (AS) undergoing surgical aortic valve replacement (SAVR) in Australia between 2002 and 2015. Methods: Using the Australian and New Zealand Society of Cardiac and Thoracic Surgeons database, we identified first-recorded SAVR for AS over 14 years. Patients’ surgical risk profiles, procedures, 30-day and 12-month outcomes were summarized before and after the introduction of transcatheter aortic valve implantation in Australia, in 2008. We applied multivariable regression models to investigate the changes over time on risk-adjusted 30-day mortality, re-hospitalization and 12-month mortality. Results: We identify a total of 18 147 patients with AS who underwent SAVR; mostly men (64%) with a mean age of 72 years. The proportion of major cardiac surgeries devoted to SAVR increased from 14% in 2002 to 20% in 2015. More SAVRs were performed electively (80% in 2002 versus 86% in 2015), and the recipients were at lower surgical risk (mean multi-risk score 3.9% in 2002 versus 3.0% in 2015). The use of bioprosthetic aortic valves increased over time (67% in 2002 to 88% in 2015). We found no significant changes in 30-day mortality, a significant decrease in 30-day readmission and minor fluctuations in 12-month mortality over the study period. Conclusion: SAVR comprises an increasingly larger proportion of all adult cardiac surgeries in Australia. There has been a greater use of bioprosthetic aortic valves, a fall in 30-day readmission but no significant changes in mortality.

AB - Background: This study describes the temporal changes in risk profiles and outcomes among patients with aortic stenosis (AS) undergoing surgical aortic valve replacement (SAVR) in Australia between 2002 and 2015. Methods: Using the Australian and New Zealand Society of Cardiac and Thoracic Surgeons database, we identified first-recorded SAVR for AS over 14 years. Patients’ surgical risk profiles, procedures, 30-day and 12-month outcomes were summarized before and after the introduction of transcatheter aortic valve implantation in Australia, in 2008. We applied multivariable regression models to investigate the changes over time on risk-adjusted 30-day mortality, re-hospitalization and 12-month mortality. Results: We identify a total of 18 147 patients with AS who underwent SAVR; mostly men (64%) with a mean age of 72 years. The proportion of major cardiac surgeries devoted to SAVR increased from 14% in 2002 to 20% in 2015. More SAVRs were performed electively (80% in 2002 versus 86% in 2015), and the recipients were at lower surgical risk (mean multi-risk score 3.9% in 2002 versus 3.0% in 2015). The use of bioprosthetic aortic valves increased over time (67% in 2002 to 88% in 2015). We found no significant changes in 30-day mortality, a significant decrease in 30-day readmission and minor fluctuations in 12-month mortality over the study period. Conclusion: SAVR comprises an increasingly larger proportion of all adult cardiac surgeries in Australia. There has been a greater use of bioprosthetic aortic valves, a fall in 30-day readmission but no significant changes in mortality.

KW - aortic stenosis

KW - surgical aortic valve replacement

KW - time trend

UR - http://www.scopus.com/inward/record.url?scp=85070757609&partnerID=8YFLogxK

U2 - 10.1111/ans.15370

DO - 10.1111/ans.15370

M3 - Article

VL - 89

SP - 1061

EP - 1067

JO - ANZ Journal of Surgery

JF - ANZ Journal of Surgery

SN - 1445-1433

IS - 9

ER -